The SELECT Trial found semaglutide to significantly reduce the risk of kidney-related complications and improve kidney function in individuals with overweight or obesity and cardiovascular disease. The study revealed that semaglutide's ability to prevent macroalbuminuria was a key factor in reducing kidney-related events.
Researchers at Okayama University have developed a novel method to produce carbon nanotube yarns with excess electrons that can harvest waste heat. The yarns achieved high thermoelectric power factors within temperatures ranging from 30 to 200 °C, making them suitable for practical applications such as fabric-based modules.
A groundbreaking study has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome. Researchers identified anti-nephrin autoantibodies as a reliable biomarker for tracking disease progression, opening new avenues for personalized treatment approaches.